Annals of Rheumatic Diseases


ISSN: 1468-2060        年代:1999
当前卷期:Volume 58  issue suppl_1     [ 查看所有卷期 ]

年代:1999
 
     Volume 58  issue suppl_1
     Volume 58  issue 1   
     Volume 58  issue 2   
     Volume 58  issue 3   
     Volume 58  issue 4   
     Volume 58  issue 5   
     Volume 58  issue 6   
     Volume 58  issue 7   
     Volume 58  issue 8   
     Volume 58  issue 9   
     Volume 58  issue 10   
     Volume 58  issue 11   
     Volume 58  issue 12   
1. Advances in targeted therapies: TNFα blockade in clinical practice
  Annals of Rheumatic Diseases,   Volume  58,   Issue  suppl_1,   1999,   Page  1-1

F CBREEDVELD,   J RKALDEN,   J SSMOLEN,  

Preview   |   PDF (37KB)

2. Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors
  Annals of Rheumatic Diseases,   Volume  58,   Issue  suppl_1,   1999,   Page  2-13

Bryant GDarnay,   Bharat BAggarwal,  

Preview   |   PDF (389KB)

3. DAP kinase and DAP-3: novel positive mediators of apoptosis
  Annals of Rheumatic Diseases,   Volume  58,   Issue  suppl_1,   1999,   Page  14-19

AdiKimchi,  

Preview   |   PDF (148KB)

4. Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis
  Annals of Rheumatic Diseases,   Volume  58,   Issue  suppl_1,   1999,   Page  20-26

Cornelis LVerweij,  

Preview   |   PDF (153KB)

5. The rationale for the current boom in anti-TNFα treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFα and minimise hazards?
  Annals of Rheumatic Diseases,   Volume  58,   Issue  suppl_1,   1999,   Page  27-31

MarcFeldmann,   JanBondeson,   Fionula MBrennan,   Brian M JFoxwell,   Ravinder NMaini,  

Preview   |   PDF (139KB)

6. The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease
  Annals of Rheumatic Diseases,   Volume  58,   Issue  suppl_1,   1999,   Page  32-39

GeorgeKollias,   EleniDouni,   GeorgeKassiotis,   DimitrisKontoyiannis,  

Preview   |   PDF (148KB)

7. Role of tumour necrosis factor α in experimental arthritis: separate activity of interleukin 1β in chronicity and cartilage destruction
  Annals of Rheumatic Diseases,   Volume  58,   Issue  suppl_1,   1999,   Page  40-48

Wim Bvan den Berg,   Leo A BJoosten,   GeorgeKollias,   Fons A Jvan de Loo,  

Preview   |   PDF (633KB)

8. Tumour necrosis factor and other cytokines in murine lupus
  Annals of Rheumatic Diseases,   Volume  58,   Issue  suppl_1,   1999,   Page  49-55

Argyrios NTheofilopoulos,   Brian RLawson,  

Preview   |   PDF (158KB)

9. Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis
  Annals of Rheumatic Diseases,   Volume  58,   Issue  suppl_1,   1999,   Page  56-60

R NMaini,   P CTaylor,   EPaleolog,   PCharles,   SBallara,   F MBrennan,   MFeldmann,  

Preview   |   PDF (153KB)

10. Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFα treatment
  Annals of Rheumatic Diseases,   Volume  58,   Issue  suppl_1,   1999,   Page  61-64

GregoryHarriman,   Lesley KHarper,   Thomas FSchaible,  

Preview   |   PDF (83KB)

首页 上一页 下一页 尾页 第1页 共24条